<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6783926\results\search\country\results.xml">
  <result pre="RdRp inhibitors, Baloxavir Marboxil has been licensed in 2018 in" exact="Japan" post="and the US, while Favipiravir is licensed for use"/>
  <result pre="US, while Favipiravir is licensed for use in humans in" exact="Japan" post="[30,31,32]. Different screening approaches, based on cells expressing the"/>
  <result pre="Province (Grant No. 2017CXGC1309); (3) Shandong Provincial Natural Science Foundation," exact="China" post="(Grant No. ZR2019MH078); (4) the Science Foundation of SDUTCM"/>
 </snippets>
</snippetsTree>
